These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11045340)

  • 21. Polyurethane stent in nasolacrimal duct obstruction.
    Ugrbaş SH
    Ophthalmology; 2001 Aug; 108(8):1369. PubMed ID: 11470678
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of lacrimal stenoses obstructions with interventional radiology: immediate and 5-year follow-up results.
    Preziosi P; Di Primio M; Erdembileg T; Mancino R; D'Este G; Cerulli L; Simonetti G
    Radiol Med; 2008 Dec; 113(8):1211-8. PubMed ID: 18784907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoscopic-assisted retrieval of retained lacrimal stent material in congenital nasolacrimal duct obstruction without dacryocystorhinostomy.
    Ng DS; Chan E; Tong FM; Chow SK; Ko ST
    Orbit; 2016; 35(2):103-5. PubMed ID: 26838355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insertion of a preloaded Monoka™ stent for congenital nasolacrimal obstruction: Intraoperative observations. A preliminary study.
    Fayet B; Racy E; Katowitz J; Katowitz W; Ruban JM; Brémond-Gignac D
    J Fr Ophtalmol; 2019 Mar; 42(3):248-254. PubMed ID: 30871792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of polyurethane nasolacrimal duct stents: in vivo studies in New Zealand rabbits.
    Wilhelm KE; Grabolle B; Urbach H; Tolba R; Schild H; Paulsen F
    Cardiovasc Intervent Radiol; 2006; 29(5):846-53. PubMed ID: 16794895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Multi-tool to Reduce Nasolacrimal Stent Complications With the Home-Removable Farson Crawford Tube.
    Haering C; Beck KB; Arnold RW
    J Pediatr Ophthalmol Strabismus; 2016; 53(1):52-4. PubMed ID: 26836004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pushed monocanalicular intubation: an alternative stenting system for the management of congenital nasolacrimal duct obstructions.
    Fayet B; Katowitz WR; Racy E; Ruban JM; Katowitz JA
    J AAPOS; 2012 Oct; 16(5):468-72. PubMed ID: 23084387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bicanalicular Silicone Stents in Endonasal Dacryocystorhinostomy: Results of a Randomized Clinical Trial.
    Fayers T; Dolman PJ
    Ophthalmology; 2016 Oct; 123(10):2255-9. PubMed ID: 27432206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term results and factors affecting patency after removal of nasolacrimal stents.
    Kim JH; Shin JH; Song HY; Kang W; Lim JO; Park SH; Ko GY; Yoon HK; Sung KB
    J Vasc Interv Radiol; 2006 Jul; 17(7):1125-30. PubMed ID: 16868165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polyurethane stents for lacrimal duct stenoses: 5-year results.
    Bertelmann E; Rieck P
    Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):677-82. PubMed ID: 16240124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biofilm colonisation in nasolacrimal stents.
    Ibáñez A; Trinidad A; García-Berrocal JR; Gómez D; San Román J; Ramírez-Camacho R
    B-ENT; 2011; 7(1):7-10. PubMed ID: 21563550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Annular electrode lacrimal duct reconstruction for improving the safety and efficacy of lacrimal stent implantation: a randomized clinical trial].
    Hu W; Guo H; Liao H; Huang X
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):13-9. PubMed ID: 26806732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of the dacryoscintigraphy in patients with nasolacrimal duct obstruction prior to endoscopic dacryocystorhinostomy.
    Kim DJ; Baek S; Chang M
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1535-1540. PubMed ID: 31037489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasolacrimal stents for the treatment of epiphora: technical problems and long-term results.
    Pinilla I; Fernández-Prieto AF; Asencio M; Arbizu A; Peláez N; Frutos R
    Orbit; 2006 Jun; 25(2):75-81. PubMed ID: 16754213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors for outcome of endoscopic dacryocystorhinostomy in patients with primary acquired nasolacrimal duct obstruction.
    Mak ST; Io IY; Wong AC
    Graefes Arch Clin Exp Ophthalmol; 2013 May; 251(5):1361-7. PubMed ID: 23250482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Powered endoscopic dacryocystorhinostomy: a decade of experience.
    Ali MJ; Psaltis AJ; Murphy J; Wormald PJ
    Ophthalmic Plast Reconstr Surg; 2015; 31(3):219-21. PubMed ID: 25162414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Monocanalicular silicone stent implantation in children with congenital nasolacrimal duct obstruction].
    Szalai I; Maneschg OA; Nagy ZZ
    Orv Hetil; 2020 Nov; 161(48):2037-2042. PubMed ID: 33249409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcomes in primary powered endoscopic dacryocystorhinostomy.
    Ali MJ; Psaltis AJ; Bassiouni A; Wormald PJ
    Br J Ophthalmol; 2014 Dec; 98(12):1678-80. PubMed ID: 24997177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized trial on silicone intubation in endoscopic mechanical dacryocystorhinostomy (SEND) for primary nasolacrimal duct obstruction.
    Chong KK; Lai FH; Ho M; Luk A; Wong BW; Young A
    Ophthalmology; 2013 Oct; 120(10):2139-45. PubMed ID: 23672972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endonasal dacryocystorhinostomy in a pediatric patient with ectrodactyly-ectodermal dysplasia after failure of external dacryocystorhinostomy and as first procedure.
    Sacchi M; Serafino M; Dragonetti A; Lembo A; Nucci P
    Ophthalmic Plast Reconstr Surg; 2013; 29(1):e27-9. PubMed ID: 23128529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.